LADENBURG THALMANN FINANCIAL SERVICES INC. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 112 filers reported holding IMMUNOMEDICS INC in Q2 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$65,000
+103.1%
3,100
+28.5%
0.00%
Q3 2019$32,000
+23.1%
2,412
+26.0%
0.00%
Q2 2019$26,000
-25.7%
1,914
+1.0%
0.00%
Q1 2019$35,0001,895
+5473.5%
0.00%
Q4 2018$0
-100.0%
34
-98.3%
0.00%
Q3 2018$42,000
-37.3%
2,000
-56.2%
0.00%
-100.0%
Q2 2018$67,0000.0%4,5710.0%0.00%0.0%
Q1 2018$67,000
+3250.0%
4,571
+3677.7%
0.00%
Q4 2017$2,000
+100.0%
121
-39.5%
0.00%
Q4 2016$1,0000.0%2000.0%0.00%
Q3 2016$1,0002000.0%0.00%
Q2 2016$0
-100.0%
200
-93.3%
0.00%
Q4 2014$14,0003,0000.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders